AI

Alpana Indulal Doshi

Director Director DIN 00343081
DIN 00343081 First appointment Apr 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2004
Shareholding value •••• Premium profile

About Alpana Indulal Doshi

Data last updated:

Alpana Indulal Doshi was a Director at Calyx Chemicals And Pharmaceuticals Limited (2004–2009) and Partner at Msd Trading Llp (2010–2012). The companies operate in Pharma and Business Services.

DIN 00343081
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20041986₹164 Cr (FY 2024)Active
Msd Trading Llp AAA-1878
Partner26 Jul 20102010Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Calyx Chemicals And Pharmaceuticals Limited
Msd Trading Llp
Premium access

Shareholding and investment profile for Alpana Indulal Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpana Indulal Doshi

Alpana Indulal Doshi was first appointed on 01 Apr 2004 as Director at Calyx Chemicals And Pharmaceuticals Limited. The most recent appointment on record is 26 Jul 2010 at Msd Trading Llp.

Alpana Indulal Doshi held 2 earlier board appointments: Calyx Chemicals And Pharmaceuticals Limited (Director, 01 Apr 2004 to 15 May 2009); Msd Trading Llp (Partner, 26 Jul 2010 to 04 Aug 2012).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available